documents: FDA-2020-P-1633-0005

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-P-1633-0005 FDA FDA-2020-P-1633 Interim Response Letter from FDA CBER to Foley Hoag, LLP (on behalf of the Microbiome Therapeutics Innovation Group) Other Letter(s) 2020-12-29T05:00:00Z 2020 12 2020-12-29T05:00:00Z   2020-12-29T20:33:10Z   0 0 09000064849d0105

Links from other tables